摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-(3,5-dichloro-4-hydroxyphenyl)-N-(3,3-dimethylbutyl)-N-(pyridin-3-ylmethyl)-1H-1,2,4-triazole-3-carboxamide | 1219012-96-0

中文名称
——
中文别名
——
英文名称
1-(3,5-dichloro-4-hydroxyphenyl)-N-(3,3-dimethylbutyl)-N-(pyridin-3-ylmethyl)-1H-1,2,4-triazole-3-carboxamide
英文别名
1-(3,5-dichloro-4-hydroxyphenyl)-N-(3,3-dimethylbutyl)-N-(pyridin-3-ylmethyl)-1,2,4-triazole-3-carboxamide
1-(3,5-dichloro-4-hydroxyphenyl)-N-(3,3-dimethylbutyl)-N-(pyridin-3-ylmethyl)-1H-1,2,4-triazole-3-carboxamide化学式
CAS
1219012-96-0
化学式
C21H23Cl2N5O2
mdl
——
分子量
448.352
InChiKey
QFCFFHYFSXGTMD-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.9
  • 重原子数:
    30
  • 可旋转键数:
    7
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.33
  • 拓扑面积:
    84.1
  • 氢给体数:
    1
  • 氢受体数:
    5

文献信息

  • Compounds, compositions and methods comprising heteroaromatic derivatives
    申请人:Doyle Kevin James
    公开号:US20100144733A1
    公开(公告)日:2010-06-10
    The present invention relates to compositions and methods for treating a disease in an animal, which disease is responsive to inhibiting of functional cystic fibrosis transmembrane conductance regulator (CFTR) polypeptide by administering to a mammal in need thereof an effective amount of a compound defined herein (including those compounds set forth in Tables 1-14 or encompassed by formulas I-XII) or compositions thereof, thereby treating the disease. The present invention particularly, relates to a method of treating diarrhea and polycystic kidney disease.
    本发明涉及用于治疗动物体内对抑制功能性囊性纤维化跨膜传导调节因子(CFTR)多肽敏感的疾病的组合物和方法,通过向需要治疗该疾病的哺乳动物中投与本文所定义的化合物的有效量(包括表1-14中列出的化合物或公式I-XII所包含的化合物)或其组合物,从而治疗该疾病。本发明特别涉及治疗腹泻和多囊肾病的方法。
  • COMPOSITIONS AND METHODS COMPRISING IMIDAZOLE AND TRIAZOLE DERIVATIVES
    申请人:Jones Graham Peter
    公开号:US20110237528A1
    公开(公告)日:2011-09-29
    The present invention relates to compositions and methods for treating a disease in an animal, which disease is responsive to inhibiting of functional cystic fibrosis transmembrane conductance regulator (CFTR) polypeptide by administering to a mammal in need thereof an effective amount of a compound defined herein (including those compounds set forth in Tables 1-3 or encompassed by formulas (I), (IA), (IB), (II), and (III)) or compositions thereof, thereby treating the disease. The present invention particularly, relates to a method of treating diarrhea and polycystic kidney disease.
    本发明涉及用于治疗动物疾病的组合物和方法,该疾病对抑制功能性囊性纤维化跨膜传导调节因子(CFTR)多肽敏感,通过向需要的哺乳动物施用本文中定义的化合物的有效量(包括表1-3中列出的化合物或被公式(I)、(IA)、(IB)、(II)和(III)所包含的化合物)或其组合物,从而治疗该疾病。本发明特别涉及治疗腹泻和多囊肾病的方法。
查看更多